Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan Tablets 160 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ 07663, Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810 ---- NDC 52343-124-90

D-1054-2019

March 07, 2019

Class II

Product summary

Firm
Rising Pharmaceuticals, Inc.
Event
Event 82337
Status
Ongoing
Classification
Class II
Quantity
35,281 bottles
Official record key
drug-enforcement:D-1054-2019

Official wording

Reason: CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products

Code information: 472180005B, exp. date 02/29/2020 472180011A, exp. date 04/30/2020 472180012A, exp. date 04/30/2020

Distribution pattern: Product was distributed to 6 major distributors who may have further distributed the product throughout the United States.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity N- nitrosodiethylamine (NDEA
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations